FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Norgestimate and Ethinyl Estradiol Tablets
Status: Discontinuation
»Therapeutic Categories: Reproductive

Expand all

Janssen Pharmaceuticals (New 06/19/2018)

Company Contact Information:
800-526-7736

Presentation Posting Date Related Information
MonoNessa (norgestimate/ethinyl estradiol) 0.250 mg/0.035 mg; (NDC 52544-247-28)(Distributed under Actavis Pharma, Inc) 06/19/2018 Due to commercial reasons, the Sponsor has decided to discontinue this product.
Ortho Tri Cyclen ® (norgestimate/ethinyl estradiol) 0.180 mg/0.035 mg + 0.215 mg/0.035 mg + 0.250 mg/0.035 mg; (NDC 50458-191-06)(NDC 50458-191-12)(NDC 50458-191-15)(NDC 50458-191-20) 06/19/2018 Due to commercial reasons, the Sponsor has decided to discontinue this product.
TriNessa (norgestimate/ethinyl estradiol) 0.180 mg/0.035 mg + 0.215 mg/0.035 mg + 0.250 mg/0.035 mg; (NDC 52544-248-28) (Distributed under Actavis Pharma, Inc) 06/19/2018 Due to commercial reasons, the Sponsor has decided to discontinue this product.
ORTHO TRI CYCLEN Lo® (norgestimate/ethinyl estradiol) 0.180 mg/0.025 mg + 0.215 mg/0.025 mg + 0.250 mg/0.025 mg ; (NDC 50458-251-06)(NDC 50458-251-12)(NDC 50458-251-15)(NDC 50458-251-20) 06/19/2018 Due to commercial reasons, the Sponsor has decided to discontinue this product.
TriNessa Lo (norgestimate/ethinyl estradiol) 0.180 mg/0.025 mg + 0.215 mg/0.025 mg + 0.250 mg/0.025 mg (NDC 52544-087-28)(Distributed under Actavis Pharma, Inc) 06/19/2018 Due to commercial reasons, the Sponsor has decided to discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English